Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer DiseaseJennifer A. Zimmer, John R. Sims, Paul Ardayfio et al.|JAMA Neurology|2025Cited by 128
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trialTao Jiang, Shengxiang Ren, Jianying Zhou et al.|Signal Transduction and Targeted Therapy|2021Cited by 94